We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,042 hedge funds and large institutions have $157B invested in Thermo Fisher Scientific in 2021 Q1 according to their latest regulatory filings, with 142 funds opening new positions, 836 increasing their positions, 766 reducing their positions, and 113 closing their positions.

New
Increased
Maintained
Reduced
Closed

37% more call options, than puts

Call options by funds: $1.21B | Put options by funds: $878M

26% more first-time investments, than exits

New positions opened: 142 | Existing positions closed: 113

9% more repeat investments, than reductions

Existing positions increased: 836 | Existing positions reduced: 766

1% more funds holding

Funds holding: 2,0312,042 (+11)

0.56% less ownership

Funds ownership: 88.17%87.61% (-0.56%)

4% less capital invested

Capital invested by funds: $164B → $157B (-$7.13B)

19% less funds holding in top 10

Funds holding in top 10: 184149 (-35)

Holders
2,042
Holders Change
+11
Holders Change %
+0.54%
% of All Funds
35.85%
Holding in Top 10
149
Holding in Top 10 Change
-35
Holding in Top 10 Change %
-19.02%
% of All Funds
2.62%
New
142
Increased
836
Reduced
766
Closed
113
Calls
$1.21B
Puts
$878M
Net Calls
+$327M
Net Calls Change
+$557M
Name Holding Trade Value Shares
Change
Change in
Stake
LIA
901
LS Investment Advisors
Michigan
$3.28M -$1.16M -2,426 -25%
CNB
902
Camden National Bank
Maine
$3.27M +$57.8K +121 +2%
CNC
903
Camden National Corporation
Maine
$3.27M +$3.43M +7,177 New
WANY
904
Wealthspire Advisors (New York)
New York
$3.27M +$1.24M +2,607 +57%
MIC
905
MU Investments Company
Japan
$3.26M -$1.22M -2,550 -26%
LAI
906
Legal Advantage Investments
California
$3.24M +$4.77K +10 +0.1%
NONA
907
Ninety One North America
New York
$3.23M -$8.28M -17,355 -71%
SA
908
Strategic Advisors
New York
$3.22M +$15.8K +33 +0.5%
CIA
909
Cohen Investment Advisors
New Hampshire
$3.21M +$259K +542 +8%
CIC
910
Crawford Investment Counsel
Georgia
$3.21M -$10.5K -22 -0.3%
CBN
911
Cadence Bank NA
Texas
$3.21M -$74K -155 -2%
IIM
912
Ipswich Investment Management
Massachusetts
$3.21M +$158K +330 +5%
RIM
913
Regent Investment Management
Kentucky
$3.21M +$14.3K +30 +0.4%
IEFM
914
IQ EQ Fund Management
Ireland
$3.19M -$236K -495 -7%
KCM
915
Kornitzer Capital Management
Kansas
$3.18M +$19.1K +40 +0.6%
SW
916
SVB Wealth
Massachusetts
$3.17M +$7.64K +16 +0.2%
FC
917
Ferris Capital
Massachusetts
$3.15M
BO
918
Bank OZK
Arkansas
$3.12M -$14.8K -31 -0.5%
OAM
919
Origin Asset Management
United Kingdom
$3.1M -$191K -400 -6%
MBT
920
Montecito Bank & Trust
California
$3.1M -$405K -848 -11%
Koshinski Asset Management
921
Koshinski Asset Management
Illinois
$3.1M +$18.6K +39 +0.6%
MF
922
Magnetar Financial
Illinois
$3.1M +$404K +846 +14%
FRA
923
Front Row Advisors
California
$3.08M +$21.5K +45 +0.7%
CS
924
Comerica Securities
Michigan
$3.07M +$103K +215 +3%
GCC
925
Guardian Capital (Canada)
Ontario, Canada
$3.07M +$196K +410 +6%

TMO Hedge Fund Activity: Q1 2021 in Review

2,042 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2021, worth a combined $157B — down 4.3% from $164B a quarter earlier.

Buyers outnumbered sellers: 142 funds opened new TMO positions and 113 closed out — a net gain of 29 holders — while 836 added to existing stakes and 766 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $374M. The largest seller was Wellington Management Group, cutting an estimated $1.02B.

  • 2,042 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2021, up from 2,031 in Q4 2020.
  • Funds reported $157B of Thermo Fisher Scientific stock for Q1 2021, down 4.3% quarter-over-quarter.
  • 142 funds opened new Thermo Fisher Scientific positions in Q1 2021 and 113 closed out, a net change of +29 holders.
  • The largest Thermo Fisher Scientific buyer in Q1 2021 was Viking Global Investors, an estimated $374M added.
  • The largest Thermo Fisher Scientific seller in Q1 2021 was Wellington Management Group, an estimated $1.02B sold.

Based on aggregated 13F filings for Q1 2021.